News
-
-
PRESS RELEASE
Onco-Innovations Initiates Polymer Process Development and Characterization Program for ONC010
Onco-Innovations announces polymer process development and analytical characterization activities for ONC010 nanoparticle inhibitor in collaboration with Nanosoft, strengthening future GMP manufacturing and clinical development -
-
-
PRESS RELEASE
Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Onco-Innovations announces hepatocyte and liver microsome metabolism studies for ONC010, its lead nanoparticle-formulated PNKP inhibitor, to support future toxicology studies and regulatory submissions -
-
-
-
-